Leading the Way in Life Science Technologies

GEN Exclusives

More »
Best Science Apps

Related to Byron to Pay $875K to Commercialize CEL-SCI's Late-Stage Cancer Drug in South Africa

  • Page 1 of 1 (3 items) 1 

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »